[MPTP parkinsonism].
Kondo
T
T
Department of Neurology, Wakayama Medical College.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D008995:Monoamine Oxidase; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000175:diagnosis; D011379:Prognosis
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D008995:Monoamine Oxidase